Completed OBSERVATIONAL NCT03923400

Jejunoileal vs Gastric GIST in the Era of Imatinib.

Characteristics and Prognosis of Jejunoileal Gastrointestinal Stromal Tumors (GISTs) in the Era of Imatinib. A Comparative Retrospective Study With Gastric GISTs.

Sponsor: Hospital Universitario Virgen de la Arrixaca

Conditions Disease-free Survival Overall Survival Recurrence

Updated 4 times since 2019 Last updated: Apr 18, 2019 Started: Nov 1, 2016 Primary completion: Jan 31, 2017 Completion: Jan 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Disease-free Survival and Overall Survival and is currently completed. Hospital Universitario Virgen de la Arrixaca leads this study, which shows 4 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
May 2019 — Jan 2021 [monthly]

Completed

First recorded

Nov 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital Universitario Virgen de la Arrixaca

Data source: Hospital Universitario Virgen de la Arrixaca

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Murcia, Spain